Urs E. Studer

Urs E. Studer

Auto-generated profile, based on publicly available information

Urs E. Studer

Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in Journal of Urology
Verified
Journal Article
Closed access
USUrs E. Studer
Urs E. Studer
FBFiona C. Burkhard
Fiona C. Burkhard
MSMartin Schumacher
Martin Schumacher
TKThomas M. Kessler
Thomas M. Kessler
HTHarriet Thoeny
Harriet Thoeny
GTGeorge N. Thalmann
George N. Thalmann
We present the long-term results of a large consecutive series of patients undergoing ileal orthotopic bladder substitution following radical cystectomy. Between April 1985 and 2005 orthotopic bladder substitution with an ileal low pressure reservoir was performed in 482 patients (including 40 women) after radical and, if possible, nerve sparing cystectomy. In 447 cases the procedure was combined with an afferent ileal isoperistaltic tubular segment. The patients were followed prospectively. In the 482 patients 61 early (less than 30 days) diversion related complications requiring prolonged hospital stay or readmission were noted and 115 late complications required treatment. At 1 year continence was good in 92% of patients during the day and in 79% at night. At last followup 93% of patients could void spontaneously. Of 442 evaluable men 99 (22.4%) reported having erections without and 68 (15.4%) with medical assistance. Ureteroileal stenosis was observed in 12 of 447 (2.7%) patients. Urethral recurrence was detected in 25 of 482 (5%) patients. A total of 15 (5%) patients received vitamin B12 substitution. Renal parenchyma decreased only in patients with preoperative or postoperative ureteral obstruction. After 10 years patients with normal renal function had no long-term acidosis and in 20 patients the incidence of osteoporosis resembled that of the normal population. Ileal orthotopic bladder substitution combined with an afferent ileal tubular segment allows for good long-term functional results provided patients are restrictively selected, postoperative instructions are followed carefully, and typical complications such as outlet obstruction and hernias are treated early.

20 April 2006 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
USUrs E. Studer
Urs E. Studer
PWPeter Whelan
Peter Whelan
WAWalter Albrecht
Walter Albrecht
JCJacques Casselman
Jacques Casselman
TRTheo de Reijke
Theo de Reijke
LCLaurence Collette
Laurence Collette
Purpose This study (EORTC 30891) attempted to demonstrate equivalent overall survival in patients with localized prostate cancer not suitable for local curative treatment treated with immediate or deferred androgen ablation. Patients and Methods We randomly assigned 985 patients with newly diagnosed prostate cancer T0-4 N0-2 M0 to receive androgen deprivation either immediately (n = 493) or on symptomatic disease progression or occurrence of serious complications (n = 492). Results Baseline characteristics were well balanced in the two groups. Median age was 73 years (range, 52 to 81). At a median follow-up of 7.8 years, 541 of 985 patients had died, mostly of prostate cancer (n = 193) or cardiovascular disease (n = 185). The overall survival hazard ratio was 1.25 (95% CI, 1.05 to 1.48; noninferiority P > .1) favoring immediate treatment, seemingly due to fewer deaths of nonprostatic cancer causes (P = .06). The time from randomization to progression of hormone refractory disease did not differ significantly, nor did prostate-cancer specific survival. The median time to the start of deferred treatment after study entry was 7 years. In this group 126 patients (25.6%) died without ever needing treatment (44% of the deaths in this arm). Conclusion Immediate androgen deprivation resulted in a modest but statistically significant increase in overall survival but no significant difference in prostate cancer mortality or symptom-free survival. This must be weighed on an individual basis against the adverse effects of life-long androgen deprivation, which may be avoided in a substantial number of patients with a deferred treatment policy.

1 May 2008 in European Urology
Verified
Journal Article
Closed access
USUrs E. Studer
Urs E. Studer
LCLaurence Collette
Laurence Collette
PWPeter Whelan
Peter Whelan
WAWalter Albrecht
Walter Albrecht
JCJacques Casselman
Jacques Casselman
MDMuriel Debois
Muriel Debois

15 October 2004 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
USUrs E. Studer
Urs E. Studer
DHDieter Hauri
Dieter Hauri
SHSilvia Hanselmann
Silvia Hanselmann
DCDominique Chollet
Dominique Chollet
HLHans-Jürg Leisinger
Hans-Jürg Leisinger
DDDaniel Dietrich
Daniel Dietrich
Purpose To determine if immediate hormonal therapy is advantageous compared with deferred treatment in newly diagnosed asymptomatic prostate cancer patients who, for any reason, were not candidates for curative local treatment. Patients and Methods Between February 1988 and February 1992, 197 patients with a median age of 76 years (range, 56 to 86 years) were randomly assigned to receive either immediate or deferred orchiectomy on symptomatic progression. The two groups did not differ significantly in clinical or laboratory parameters; 67% had T3-4 tumors and 20% had lymph node metastases. Patient accrual was stopped prematurely because of a similar competing trial. Therefore, observation time was prolonged to achieve the desired number of events and statistical power. Results Deferred orchiectomy was necessary in 58% of the patients. Median time to disease progression was 2.8 years less than for patients with immediate orchiectomy. However, overall pain-free time from random assignment to symptomatic progression after immediate or deferred orchiectomy, and performance status, were identical in both groups. Cancer-specific survival tended to be longer in the immediate group (P = .09) but there was no difference in overall survival between the two groups (P = .96). The median hemoglobin value decreased significantly after immediate orchiectomy (P < .001). Conclusion For elderly, asymptomatic patients not undergoing curative local treatment, we were unable to show any major advantage of immediate compared with deferred hormonal treatment regarding quality of life or overall survival in our limited number of patients. Disabling complications were prevented in the deferred-treatment arm by careful follow-up; 42% of these patients never required any tumor-specific treatment.

1 April 2011 in European Urology
Verified
Journal Article
Closed access
PZPascal Zehnder
Pascal Zehnder
BRBeat Roth
Beat Roth
FBFrédéric Birkhäuser
Frédéric Birkhäuser
SSSilvia Schneider
Silvia Schneider
RSRolf Schmutz
Rolf Schmutz
USUrs E. Studer
Urs E. Studer

1 November 2014 in European Urology
Verified
Journal Article
Closed access
USUrs E. Studer
Urs E. Studer
PWPeter Whelan
Peter Whelan
FWFlorian Wimpissinger
Florian Wimpissinger
JCJacques Casselman
Jacques Casselman
TRTheo M. de Reijke
Theo M. de Reijke
LCLaurence Collette
Laurence Collette